D Ratnasinghe

1.7k total citations
22 papers, 1.4k citations indexed

About

D Ratnasinghe is a scholar working on Molecular Biology, Cancer Research and Pharmacology. According to data from OpenAlex, D Ratnasinghe has authored 22 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Cancer Research and 4 papers in Pharmacology. Recurrent topics in D Ratnasinghe's work include Glutathione Transferases and Polymorphisms (8 papers), Carcinogens and Genotoxicity Assessment (5 papers) and Cancer, Lipids, and Metabolism (4 papers). D Ratnasinghe is often cited by papers focused on Glutathione Transferases and Polymorphisms (8 papers), Carcinogens and Genotoxicity Assessment (5 papers) and Cancer, Lipids, and Metabolism (4 papers). D Ratnasinghe collaborates with scholars based in United States, China and Finland. D Ratnasinghe's co-authors include Philip R. Taylor, Demetrius Albanes, Jarmo Virtamo, J A Tangrea, Joseph A. Tangrea, Michael Barrett, Fred F. Kadlubar, You‐Lin Qiao, M. Robyn Andersen and P R Taylor and has published in prestigious journals such as Cancer Letters, Chemical Research in Toxicology and Mutation research. Fundamental and molecular mechanisms of mutagenesis.

In The Last Decade

D Ratnasinghe

22 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D Ratnasinghe United States 19 763 394 233 201 171 22 1.4k
Mirko Tarocchi Italy 19 771 1.0× 307 0.8× 82 0.4× 172 0.9× 76 0.4× 37 1.9k
Cristina Cartiglia Italy 27 1.1k 1.5× 530 1.3× 79 0.3× 115 0.6× 75 0.4× 42 1.9k
Elba S. Vázquez Argentina 23 1.2k 1.6× 292 0.7× 182 0.8× 296 1.5× 72 0.4× 89 1.8k
Aya Naiki‐Ito Japan 25 870 1.1× 279 0.7× 93 0.4× 245 1.2× 74 0.4× 99 1.7k
A. Hautefeuille France 26 892 1.2× 720 1.8× 122 0.5× 416 2.1× 57 0.3× 44 1.8k
Ann H. Rosendahl Sweden 19 486 0.6× 251 0.6× 112 0.5× 534 2.7× 93 0.5× 55 1.2k
David R. Plowchalk United States 20 270 0.4× 149 0.4× 86 0.4× 264 1.3× 135 0.8× 27 1.4k
Carlos Fernández Spain 20 608 0.8× 164 0.4× 55 0.2× 172 0.9× 53 0.3× 24 1.3k
Carl L. Alden United States 22 397 0.5× 441 1.1× 115 0.5× 175 0.9× 183 1.1× 65 1.4k
Jyh‐Ming Chow Taiwan 25 903 1.2× 241 0.6× 49 0.2× 286 1.4× 234 1.4× 40 1.7k

Countries citing papers authored by D Ratnasinghe

Since Specialization
Citations

This map shows the geographic impact of D Ratnasinghe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Ratnasinghe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Ratnasinghe more than expected).

Fields of papers citing papers by D Ratnasinghe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Ratnasinghe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Ratnasinghe. The network helps show where D Ratnasinghe may publish in the future.

Co-authorship network of co-authors of D Ratnasinghe

This figure shows the co-authorship network connecting the top 25 collaborators of D Ratnasinghe. A scholar is included among the top collaborators of D Ratnasinghe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Ratnasinghe. D Ratnasinghe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ning, Baitang, Susan Nowell, Carol Sweeney, et al.. (2005). Common genetic polymorphisms in the 5′-flanking Region of the SULT1A1 gene: haplotypes and their association with platelet enzymatic activity. Pharmacogenetics and Genomics. 15(7). 465–473. 29 indexed citations
2.
Nowell, Susan, D Ratnasinghe, Christine B. Ambrosone, et al.. (2004). Association of SULT1A1 Phenotype and Genotype with Prostate Cancer Risk in African-Americans and Caucasians. Cancer Epidemiology Biomarkers & Prevention. 13(2). 270–276. 70 indexed citations
3.
Ning, Baitang, Charles Wang, Fabrice Morel, et al.. (2003). Human glutathione S-transferase A2 polymorphisms. Pharmacogenetics. 14(1). 35–44. 41 indexed citations
4.
Turesky, Robert J., James P. Freeman, Ricky D. Holland, et al.. (2003). Identification of Aminobiphenyl Derivatives in Commercial Hair Dyes. Chemical Research in Toxicology. 16(9). 1162–1173. 121 indexed citations
5.
Misra, Rakesh R., D Ratnasinghe, Joseph A. Tangrea, et al.. (2003). Polymorphisms in the DNA repair genes XPD, XRCC1, XRCC3, and APE/ref-1, and the risk of lung cancer amongmale smokers in Finland. Cancer Letters. 191(2). 171–178. 156 indexed citations
6.
Ratnasinghe, D, Shu Xiang Yao, Michele R. Forman, et al.. (2003). Gene-environment interactions between the codon 194 polymorphism of XRCC1 and antioxidants influence lung cancer risk.. PubMed. 23(1B). 627–32. 20 indexed citations
7.
Nowell, Susan, Brian Coles, Rashmi Sinha, et al.. (2002). Analysis of total meat intake and exposure to individual heterocyclic amines in a case-control study of colorectal cancer: contribution of metabolic variation to risk. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 506-507. 175–185. 117 indexed citations
8.
Ratnasinghe, D, Shu Xiang Yao, J A Tangrea, et al.. (2001). Polymorphisms of the DNA repair gene XRCC1 and lung cancer risk.. PubMed. 10(2). 119–23. 158 indexed citations
9.
Misra, Rakesh R., Joseph A. Tangrea, Jarmo Virtamo, et al.. (2001). Variation in the promoter region of the myeloperoxidase gene is not directly related to lung cancer risk among male smokers in Finland. Cancer Letters. 164(2). 161–167. 53 indexed citations
10.
Ratnasinghe, D, et al.. (2001). Cyclooxygenase-2, P-glycoprotein-170 and drug resistance; is chemoprevention against multidrug resistance possible?. PubMed. 21(3C). 2141–7. 71 indexed citations
11.
Ratnasinghe, D, Joseph A. Tangrea, Claudia Stewart, et al.. (2001). Influence of antioxidants and the CYP1A1 isoleucine to valine polymorphism on the smoking--lung cancer association.. PubMed. 21(2B). 1295–9. 5 indexed citations
12.
Ratnasinghe, D, J A Tangrea, M. Robyn Andersen, et al.. (2000). Glutathione peroxidase codon 198 polymorphism variant increases lung cancer risk.. PubMed. 60(22). 6381–3. 192 indexed citations
13.
14.
Ratnasinghe, D, Joseph A. Tangrea, Michele R. Forman, et al.. (2000). Serum tocopherols, selenium and lung cancer risk among tin miners in China. Cancer Causes & Control. 11(2). 129–135. 41 indexed citations
15.
Roth, Mark J., Sanford M. Dawsey, Joseph A. Tangrea, et al.. (2000). Association between GSTM1*0 and squamous dysplasia of the esophagus in the high risk region of Linxian, China. Cancer Letters. 156(1). 73–81. 37 indexed citations
16.
Woodson, K., D Ratnasinghe, N K Bhat, et al.. (1999). Prevalence of disease-related DNA polymorphisms among participants in a large cancer prevention trial. European Journal of Cancer Prevention. 8(5). 441–448. 26 indexed citations
17.
Ratnasinghe, D, et al.. (1999). Cancer Knowledge and Misconceptions Among Immigrant Salvadorean Men in the Washington, D.C. Area. PubMed. 1(4). 207–213. 5 indexed citations
18.
Ratnasinghe, D, Joseph A. Tangrea, Mark J. Roth, et al.. (1999). Expression of cyclooxygenase-2 in human adenocarcinomas of the gastric cardia and corpus.. Oncology Reports. 6(5). 965–8. 27 indexed citations
19.
Ratnasinghe, D, Joseph A. Tangrea, Mark J. Roth, et al.. (1999). Expression of cyclooxygenase-2 in human squamous cell carcinoma of the esophagus; an immunohistochemical survey.. PubMed. 19(1A). 171–4. 85 indexed citations
20.
Ratnasinghe, D, Paul J. Limburg, & Joseph A. Tangrea. (1999). Cyclooxygenase-2, non-steroidal anti-inflammatory drugs and cancer of the esophagus. 12(4). 178–181. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mirko Tarocchi Breakdown of academic impact, for papers by Cristina Cartiglia Breakdown of academic impact, for papers by Elba S. Vázquez Breakdown of academic impact, for papers by Aya Naiki‐Ito Breakdown of academic impact, for papers by A. Hautefeuille Breakdown of academic impact, for papers by Ann H. Rosendahl Breakdown of academic impact, for papers by David R. Plowchalk Breakdown of academic impact, for papers by Carlos Fernández Breakdown of academic impact, for papers by Carl L. Alden Breakdown of academic impact, for papers by Jyh‐Ming Chow
Rankless by CCL
2026